NFKB1 and neoplasm: Notably, NF-κB suppression—frequently reported in immune and stromal cells under μg—emerges as a critical regulatory node, as its inhibition reduces transcription of pro-inflammatory cytokines and costimulatory molecules, thereby weakening antitumor immunity and shaping a tumor-permissive microenvironment.